Foxx, Virginia
U.S. Representative NC-5 Republican PartyCongressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.
Latest disclosed trades
Latest 10 of 981| Ticker | Type | Traded |
|---|---|---|
| ARLP | Buy | Feb 13, 2026 |
| PSA | Sell | Jan 12, 2026 |
| HTGC | Sell | Jan 12, 2026 |
| EFC | Buy | Dec 30, 2025 |
| HTGC | Buy | Nov 19, 2025 |
| ARLP | Buy | Nov 17, 2025 |
| ARLP | Buy | Nov 14, 2025 |
| — Ellington Financial Inc. 7.00% S | Buy | Sep 30, 2025 |
| HTGC | Sell | Sep 25, 2025 |
| ARLP | Sell | Sep 25, 2025 |
Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.
Foxx, Virginia stock trade activity
FilingIQ has indexed 981 congressional stock trade disclosures for Foxx, Virginia. The most recent disclosed transaction is dated Feb 13, 2026.
Across the full history, 773 purchases and 205 sales have been disclosed under the STOCK Act.
Top tickers traded by Foxx, Virginia
Frequently asked
- How many stock trades has Foxx, Virginia disclosed?
- FilingIQ tracks 981 Periodic Transaction Report disclosures for Foxx, Virginia, with the most recent dated Feb 13, 2026. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
- Is Foxx, Virginia a net buyer or net seller?
- Across the disclosed trade history, 773 (79%) were purchases and 205 (21%) were sales. Compensation and exchanges are filtered out of these counts.
- Where does FilingIQ's data on Foxx, Virginia come from?
- Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.
Methodology & sources
Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.